A sterile clinical trials

A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis

This study is testing a new medicine, called Rosnilimab, for people aged 18 and over with moderate to severe rheumatoid arthritis. Researchers want to see if it helps reduce symptoms and is safe to use, compared to a dummy treatment.